NSEAllotment of Securities1 Jul 2026 · 1 Jul 2026, 06:19 pm

Allotment of Securities

Vimta Labs Limited · VIMTALABS

✦ AI SummaryFundraise

Vimta Labs Limited has informed the Exchange regarding allotment of 17,549 securities pursuant to ESOP/ESPS at its meeting held on July 01, 2026. The paid-up share capital of the Company has increased from ₹ 8,93,38,710 consisting of 4,46,69,355 equity shares having a face value of ₹ 2/- each to ₹ 8,93,73,808 consisting of 4,46,86,904 equity shares having a face value of ₹ 2/- each.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Vimta Labs Limited has informed the Exchange regarding allotment of 17549 securities pursuant to ESOP/ESPS at its meeting held on July 01, 2026

Attachments (1)

📄

VIMTALABS_01072026181728_Reg_30.pdf

pdf

Download →
View document text
imla Vimta Labs Limited Registered Office 142, IDA Phase II, Cherlapally Hyderabad-500 051, Telangana, India T: .91 40 27264141 F: +91 40 27263657 Driven byQuality. Inspired byScience. VLL\SE\026\2026-27 Date: 01.07.2026 B S E Limited, National Stock Exchange ofIndia Limited, PJ Towers, Dalal Street, “Exchange Plaza”, Bandra, Kurla Complex, Mumbai 400001. Bandra (E), Mumbai 400051. Scrip Code: 524394 Trading Symbol: VIMTALABS Dear Sir/Madam, Sub: Mlotment ofEmployee Stock Options under “Vimta Labs Employee Stock Option Plan 2021” Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the ESOT’ Allotment Committee ofthe Board ofDirectors ofthe Company at their meeting held on July 2026, has allotted 17,549 equity shares offace value oftZ/- each, to the eligible employees ofthe Company underVimta Labs Employee Stock Option Plan 2021. Thepaid-up share capital ofthe Companyhas accordinglyincreased from Z 8,93,38,710 consisting of 4,46,69,355 equity shares having a face value of t 2/- each to Z .8,93,73,808 consisting of 4,46,86,904 equity shares having a face value ofZ 2/- each. Further, we would like to confirm that the above allotted shares shall rank pan passu with the existing equity shares ofthe Company and the Company is in the process ofcompleting the other formalities with respect to listing ofthe said allotted shares. The details required as disclosure under Part E, Regulation 10(c) of SEBI ESOP Regulations are enclosed as “Annexure-A”. This is for yourinformation and records. Thanking you, ForVIMTA LABS LIMITED Su~aniVasireddi Company Secretary & Compliance Officer Plot No. 5, Life Sciences Facility, Neovantage Science&Technology Park Private Limited, Siamirpet, GenomeValley, Turkapally Medchal-Malkajgiri, Hyderabad-500101, Telangana, India.T: +91 4067404040 E : mdoffice@vimta.com URL:wwwvimta.com GIN: L24110TG1990PLG011977 Vimta Labs Limited * Registered Office 162, IDAPhaseII, Cherlapally Hyderabad-500 051,Telangana, India T: ~91 4027264141 Is Driven by Quality. Inspired byScience. F : +91 4027263657 Annexure-A Disclosure under Part E pursuant to Regulation 10(c) of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 SI. Particulars Details Company name and address of Vimta Labs Limited Registered Office: Plot No. 142, IDA, Phase-Il, Cherlapally, Hyderabad, Telangana 500051 2 Name of the recognised Stock BSE Limited Exchanges on which the company’s National Stock Exchange ofIndia limited shares are listed 3 Filing date ofthe statement referred in BSE Limited regulation 10(b) of the Securities and Fthng date: 28.07.2021; The Company had received ‘in- Exchange Board ofIndi.a (Share Based Employee Benefits and Sweat Equity) principle’ listing approval from BSE vide letter dated Regulations, 2021 with the recognized 15.09.2021 for 6,63,234 equity shares. Stock Exchange Post Bonus Issue annlication: Date ofApplication- 01”July 2025. The Company had received ‘in-principle’ listing approval from BSE vide letter dated 29.08.2025 for additional 5,18,260 equity shares in addition to the above in-principle approval letter. National Stock Exchange ofIndia Limited Filing date: 28.07.2021; The Company had received ‘in- principle’ listing approval from NSE vide letter dated 06.08.2021 for 6,63,234 equity shares. Post Bonus Issue anplication: Date ofApplication- 0I”July 2025. The Company had received ‘in-principle’ listing approval from NSE vide letter dated 01.09.2025 for additional 5,18,260 equity shares in addition to the above in-principle approval letter. 4 FilingNumber, ifany BSE: DCS/FL/MJ/ESOP-IP/1472/2021-22 BSE: DCS/ESOP/IP/NB/3709/2025-26 NSE: NSE/LIST/27779 NSE: NSE/LIST/49464 5 Tide ofthe Scheme pursuant to which Vimta Labs Employee Stock Option Plan 2021 shares are issued, ifany: 6 Kind ofsecurity to be listed Equity Shares 7 Parvalue ofthe shares PlotNo. 5, LifeSciences Facility, NeovantageScience &Technology Park Private Limited, Sharnirpet Ge Medchal-Malkajgiri, Hyderabad-500 101,Telangana, India. T: +91 40 67404040 F: mdoffice@vimta.com CIN : L24110TG1990PLC011977 Vimta Labs Limited Registered Office 142, IDA Phase II, Cherlapally Hyderabad-500 051,Telangana, India T: +91 40 27264141 F: +914027263657 Driven byQuality. Inspired byScience. Particulars Details Date ofissue ofshares O1~July 2026 Number ofshares issued 17,549 Share Certificate No., ifapplicable NotApplicable. Distinctive number of the share, if 48369356-48386904(Both Inclusive) applicable: ISIN Number ofthe shares ifissued in 1NE579C01029 Demat Exercise price per share Z 2/- Premiurñ per share NotApplicable. Total Issued shares after this issue 4,46,86,904 Total issued share capital after this ~ 8,93,73,808 issue Details ofany lock-in on the shares NotApplicable Date ofexpiry oflock-in NotApplicable Whether shares are identical in all All equity shares of the Company allotted pursuant to respects to existing shares? If not, exercise of stock options shall rank pari-passu with the when will they become identical? existin. e.ui shares ofthe Comian Details oflisting fees, ifpayable NotApplicable Plot No. 5, Life Sciences Facility, Neovantage Science &Technology Park Private Limited, Shamirpet, GenomeValley, Turkapally Medchal-Malkajgiri, Hyderabad-500101, Telangana. India.T: +91 40 67404040 E: mdoffice@vimta.com URL : www.vimta.com GIN L24110TG1990PLC011977